News

This antibody candidate is now undergoing preclinical development activities in preparation for advancement to clinical trials, with an anticipated IND filing next year. CGEN-15029 is one of multiple

The RAC also issued recommendations on several design elements of the research and clinical development program. DTX301 is an adeno-associated virus (AAV) gene therapy product being developed to

The objective of this pharmacokinetic proof of concept study was to assess two prospective formulations of Hydrocodone DETERx in a bioavailability clinical study. The primary goals were to

It gives Anavex a seven year window of commercial exclusivity in the US in the area of infantile spasms, prioritized consultation by the FDA on clinical studies and

As per the terms of the collaboration deal, the companies will supply their respective products and equally share the trial costs. Genentech will manage the trial, which expects

The final agreement will be signed, inter alia, subject to the completion of an initial clinical trial in the technology to the satisfaction of Therapix, and the completion

"We selected Theradex to assist the Company in pursuing our proposed studies in Hodgkin’s Lymphoma because of Theradex’s invaluable assistance in finalizing our prior IND with the FDA

As part of the collaboration, Kangstem Biotech will provide iNSCs to ORIG3N for use in its disease-modeling platform. Kangstem Biotech has developed a novel approach to generating patient-specific

This UCART19 clinical trial is sponsored by Servier in close collaboration with Pfizer. The pediatric Phase I is an open label, non-comparative, monocenter study to evaluate the safety